Skip to main content

Peer Review reports

From: Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients

Original Submission
8 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
14 Jan 2022 Reviewed Reviewer Report
24 Feb 2022 Reviewed Reviewer Report
31 Mar 2022 Author responded Author comments - Apostolos Tsiachristas
Resubmission - Version 3
31 Mar 2022 Submitted Manuscript version 3
4 Apr 2022 Author responded Author comments - Apostolos Tsiachristas
Resubmission - Version 4
4 Apr 2022 Submitted Manuscript version 4
7 Apr 2022 Author responded Author comments - Apostolos Tsiachristas
Resubmission - Version 5
7 Apr 2022 Submitted Manuscript version 5
13 Apr 2022 Reviewed Reviewer Report
18 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
19 Apr 2022 Editorially accepted
26 Apr 2022 Article published 10.1186/s12885-022-09576-3

You can find further information about peer review here.

Back to article page